Society for Clinical Vascular Surgery

SCVS Home SCVS Home Past & Future Symposia Past & Future Symposia

Back to 2024 Display Posters

Assessment Of Long-term Durability Of Left Subclavian Retrograde In Situ Laser Fenestration In Thoracic Endovascular Aortic Repair
William G. Montgomery, MS, Fletcher Pierce, BA, Jean Panneton, MD.
Eastern Virginia Medical School, Norfolk, VA, USA.

Objectives:Retrograde laser fenestration of the left subclavian artery (LSA) is a relatively simple and effective intraoperative method for left subclavian artery revascularization. However, long-term outcomes of this technique have yet to be studied. The aim of this study is to present long-term outcomes of in-situ retrograde laser fenestration of the LSA.Methods:This is a retrospective study of 33 consecutive patients who underwent TEVAR with LSA revascularization by retrograde in situ laser fenestration between 2009 and 2013. Our institution’s database contains 97 patients having undergone TEVAR with retrograde laser fenestration of the great vessels, this study only included patients having undergone LSA laser fenestration 10 years ago or more. Postoperative clinical follow-up and computed tomography angiography (CTA) were reviewed to assess late laser fenestration-related morbidity including reintervention, endoleak, and mortality.Results:TEVAR with retrograde laser fenestration of the LSA was performed in 33 total patients (16 males, 17 females, aged 60.0 ±13.0 years). Successful LSA stenting was achieved via retrograde laser fenestration in 100% of cases. Average hospital length of stay was 10.4 ± 9.2 days. One patient underwent repair of type 1c of LSA stent on postoperative day 8. Two patients died in the immediate 30-day postoperative period. Two additional patients were lost to follow-up within the first 30 days. Of the patients that maintained follow up to >30 days (n=29) there was a mean follow up length of 6.2 ± 4.3 years of imaging and 6.4 ± 4.1 years of clinical follow up.There were eight late deaths including 1 aortic related mortality. There have been no fenestration-related mortality to date and no incidences of type III endoleak. CT imaging showed 96.6% stent patency in the late postoperative period with one LSA stent found to be occluded 6.1 years after surgery. Two patients (6.9%) were found to have late type 1c endoleak and underwent distal extension of the LSA stent at 17.3 and 30.2 months postoperatively.Conclusions:Retrograde laser fenestration for LSA revascularization during TEVAR is a durable, long-term treatment option for management of aortic pathologies requiring proximal seal in zone 2. Laser fenestration carries an excellent technical success rate, low fenestration-related complications, and competitive long-term stent patency.
Back to 2024 Display Posters